Logo image of CRH

CRH PLC (CRH) Stock Fundamental Analysis

NYSE:CRH - New York Stock Exchange, Inc. - IE0001827041 - Common Stock - Currency: USD

99.79  +0.7 (+0.71%)

After market: 99.79 0 (0%)

Fundamental Rating

5

Overall CRH gets a fundamental rating of 5 out of 10. We evaluated CRH against 12 industry peers in the Construction Materials industry. There are concerns on the financial health of CRH while its profitability can be described as average. CRH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CRH had positive earnings in the past year.
CRH had positive earnings in 4 of the past 5 years.
CRH had a positive operating cash flow in 4 of the past 5 years.
CRH Yearly Net Income VS EBIT VS OCF VS FCFCRH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

1.2 Ratios

CRH's Return On Assets of 11.65% is in line compared to the rest of the industry. CRH outperforms 58.33% of its industry peers.
Looking at the Return On Equity, with a value of 27.28%, CRH belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
The Return On Invested Capital of CRH (15.49%) is better than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRH is significantly below the industry average of 19.95%.
The last Return On Invested Capital (15.49%) for CRH is above the 3 year average (8.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.65%
ROE 27.28%
ROIC 15.49%
ROA(3y)7.03%
ROA(5y)5.44%
ROE(3y)15.22%
ROE(5y)12.08%
ROIC(3y)8.05%
ROIC(5y)7.11%
CRH Yearly ROA, ROE, ROICCRH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

The Profit Margin of CRH (9.68%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CRH has declined.
CRH has a Operating Margin (13.20%) which is comparable to the rest of the industry.
CRH's Operating Margin has improved in the last couple of years.
CRH has a Gross Margin of 34.88%. This is amongst the best in the industry. CRH outperforms 83.33% of its industry peers.
CRH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.2%
PM (TTM) 9.68%
GM 34.88%
OM growth 3Y6.45%
OM growth 5Y7.01%
PM growth 3Y30.76%
PM growth 5Y-2.84%
GM growth 3Y0.1%
GM growth 5Y0.64%
CRH Yearly Profit, Operating, Gross MarginsCRH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

3

2. Health

2.1 Basic Checks

CRH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
There is no outstanding debt for CRH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRH Yearly Shares OutstandingCRH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M
CRH Yearly Total Debt VS Total AssetsCRH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 3.92 indicates that CRH is not in any danger for bankruptcy at the moment.
CRH has a Altman-Z score (3.92) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.50 indicates that CRH is somewhat dependend on debt financing.
CRH has a Debt to Equity ratio (0.50) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 3.92
ROIC/WACC2.35
WACC6.59%
CRH Yearly LT Debt VS Equity VS FCFCRH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.3 Liquidity

CRH has a Current Ratio of 1.39. This is a normal value and indicates that CRH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.39, CRH is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Quick Ratio of 0.96 indicates that CRH may have some problems paying its short term obligations.
With a Quick ratio value of 0.96, CRH is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.96
CRH Yearly Current Assets VS Current LiabilitesCRH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

4

3. Growth

3.1 Past

The earnings per share for CRH have decreased strongly by -13.66% in the last year.
The Earnings Per Share has been growing slightly by 4.85% on average over the past years.
The Revenue has been growing slightly by 6.80% in the past year.
The Revenue has been growing slightly by 4.95% on average over the past years.
EPS 1Y (TTM)-13.66%
EPS 3Y45.34%
EPS 5Y4.85%
EPS Q2Q%N/A
Revenue 1Y (TTM)6.8%
Revenue growth 3Y8.2%
Revenue growth 5Y4.95%
Sales Q2Q%N/A

3.2 Future

CRH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.26% yearly.
Based on estimates for the next years, CRH will show a small growth in Revenue. The Revenue will grow by 4.77% on average per year.
EPS Next Y21.9%
EPS Next 2Y16.7%
EPS Next 3Y15.19%
EPS Next 5Y11.26%
Revenue Next Year2.4%
Revenue Next 2Y4.66%
Revenue Next 3Y4.93%
Revenue Next 5Y4.77%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRH Yearly Revenue VS EstimatesCRH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B 40B
CRH Yearly EPS VS EstimatesCRH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.30, which indicates a correct valuation of CRH.
Based on the Price/Earnings ratio, CRH is valued cheaper than 83.33% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.51. CRH is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 16.18, the valuation of CRH can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRH indicates a rather cheap valuation: CRH is cheaper than 83.33% of the companies listed in the same industry.
CRH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 93.88.
Industry RankSector Rank
PE 12.3
Fwd PE 16.18
CRH Price Earnings VS Forward Price EarningsCRH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRH is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.31
CRH Per share dataCRH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

CRH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRH has a very decent profitability rating, which may justify a higher PE ratio.
CRH's earnings are expected to grow with 15.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)2.53
EPS Next 2Y16.7%
EPS Next 3Y15.19%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.39%, CRH has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.42, CRH pays a better dividend. On top of this CRH pays more dividend than 83.33% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.27, CRH is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.39%

5.2 History

The dividend of CRH is nicely growing with an annual growth rate of 11.83%!
CRH has been paying a dividend for at least 10 years, so it has a reliable track record.
As CRH did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)11.83%
Div Incr Years7
Div Non Decr Years7
CRH Yearly Dividends per shareCRH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

CRH pays out 40.37% of its income as dividend. This is a bit on the high side, but may be sustainable.
CRH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP40.37%
EPS Next 2Y16.7%
EPS Next 3Y15.19%
CRH Yearly Income VS Free CF VS DividendCRH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B
CRH Dividend Payout.CRH Dividend Payout, showing the Payout Ratio.CRH Dividend Payout.PayoutRetained Earnings

CRH PLC

NYSE:CRH (1/30/2025, 5:57:45 PM)

After market: 99.79 0 (0%)

99.79

+0.7 (+0.71%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)N/A N/A
Inst Owners91.92%
Inst Owner Change0.75%
Ins Owners0.03%
Ins Owner Change0%
Market Cap71.02B
Analysts83.2
Price Target116.56 (16.81%)
Short Float %1.76%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield 1.39%
Yearly Dividend1.31
Dividend Growth(5Y)11.83%
DP40.37%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.34%
Min EPS beat(2)-7.83%
Max EPS beat(2)1.15%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.72%
Min Revenue beat(2)-6.05%
Max Revenue beat(2)-1.38%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.34%
PT rev (3m)9.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.31%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE 12.3
Fwd PE 16.18
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 3.25
P/tB 7.2
EV/EBITDA 8.31
EPS(TTM)8.11
EY8.13%
EPS(NY)6.17
Fwd EY6.18%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS86.63
BVpS30.74
TBVpS13.86
PEG (NY)0.56
PEG (5Y)2.53
Profitability
Industry RankSector Rank
ROA 11.65%
ROE 27.28%
ROCE 20.08%
ROIC 15.49%
ROICexc 16.79%
ROICexgc 24.68%
OM 13.2%
PM (TTM) 9.68%
GM 34.88%
FCFM N/A
ROA(3y)7.03%
ROA(5y)5.44%
ROE(3y)15.22%
ROE(5y)12.08%
ROIC(3y)8.05%
ROIC(5y)7.11%
ROICexc(3y)9.7%
ROICexc(5y)8.76%
ROICexgc(3y)14.39%
ROICexgc(5y)12.91%
ROCE(3y)10.42%
ROCE(5y)9.43%
ROICexcg growth 3Y14.23%
ROICexcg growth 5Y3.01%
ROICexc growth 3Y13.51%
ROICexc growth 5Y5.92%
OM growth 3Y6.45%
OM growth 5Y7.01%
PM growth 3Y30.76%
PM growth 5Y-2.84%
GM growth 3Y0.1%
GM growth 5Y0.64%
F-ScoreN/A
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA 1.12
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.96
Altman-Z 3.92
F-ScoreN/A
WACC6.59%
ROIC/WACC2.35
Cap/Depr(3y)99.28%
Cap/Depr(5y)86.71%
Cap/Sales(3y)5.09%
Cap/Sales(5y)4.75%
Profit Quality(3y)86.61%
Profit Quality(5y)133.63%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.66%
EPS 3Y45.34%
EPS 5Y4.85%
EPS Q2Q%N/A
EPS Next Y21.9%
EPS Next 2Y16.7%
EPS Next 3Y15.19%
EPS Next 5Y11.26%
Revenue 1Y (TTM)6.8%
Revenue growth 3Y8.2%
Revenue growth 5Y4.95%
Sales Q2Q%N/A
Revenue Next Year2.4%
Revenue Next 2Y4.66%
Revenue Next 3Y4.93%
Revenue Next 5Y4.77%
EBIT growth 1Y15.91%
EBIT growth 3Y15.19%
EBIT growth 5Y12.3%
EBIT Next Year51.63%
EBIT Next 3Y21.31%
EBIT Next 5Y13.83%
FCF growth 1Y42.48%
FCF growth 3Y2.84%
FCF growth 5Y28.26%
OCF growth 1Y32.03%
OCF growth 3Y8.41%
OCF growth 5Y17.44%